186 related articles for article (PubMed ID: 10484043)
21. Growth factors as therapeutics for diabetic neuropathy.
Calcutt NA; Jolivalt CG; Fernyhough P
Curr Drug Targets; 2008 Jan; 9(1):47-59. PubMed ID: 18220712
[TBL] [Abstract][Full Text] [Related]
22. Growth factors and diabetic neuropathy.
Thomas PK
Diabet Med; 1994 Oct; 11(8):732-9. PubMed ID: 7851066
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy.
Zhuang HX; Wuarin L; Fei ZJ; Ishii DN
J Pharmacol Exp Ther; 1997 Oct; 283(1):366-74. PubMed ID: 9336345
[TBL] [Abstract][Full Text] [Related]
24. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy.
Ishii DN
Brain Res Brain Res Rev; 1995 Jan; 20(1):47-67. PubMed ID: 7711767
[TBL] [Abstract][Full Text] [Related]
25. Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat.
Fernyhough P; Diemel LT; Hardy J; Brewster WJ; Mohiuddin L; Tomlinson DR
Eur J Neurosci; 1995 May; 7(5):1107-10. PubMed ID: 7613616
[TBL] [Abstract][Full Text] [Related]
26. Peripheral neuropathies and neurotrophic factors: animal models and clinical perspectives.
McMahon SB; Priestley JV
Curr Opin Neurobiol; 1995 Oct; 5(5):616-24. PubMed ID: 8580713
[TBL] [Abstract][Full Text] [Related]
27. [Diabetic neuropathy: clinical and experimental progress in its pathogenesis and treatment].
Maeda K; Yasuda H
Nihon Rinsho; 1999 Mar; 57(3):578-83. PubMed ID: 10199137
[TBL] [Abstract][Full Text] [Related]
28. Diabetic neuropathy and nerve regeneration.
Yasuda H; Terada M; Maeda K; Kogawa S; Sanada M; Haneda M; Kashiwagi A; Kikkawa R
Prog Neurobiol; 2003 Mar; 69(4):229-85. PubMed ID: 12757748
[TBL] [Abstract][Full Text] [Related]
29. Beneficial actions of neurotrophin treatment on diabetes-induced hypoalgesia in mice.
Christianson JA; Ryals JM; McCarson KE; Wright DE
J Pain; 2003 Nov; 4(9):493-504. PubMed ID: 14636817
[TBL] [Abstract][Full Text] [Related]
30. Molecular forms of NGF in human and rat neuropathic tissues: decreased NGF precursor-like immunoreactivity in human diabetic skin.
Yiangou Y; Facer P; Sinicropi DV; Boucher TJ; Bennett DL; McMahon SB; Anand P
J Peripher Nerv Syst; 2002 Sep; 7(3):190-7. PubMed ID: 12365567
[TBL] [Abstract][Full Text] [Related]
31. Preserved Expression of Skin Neurotrophic Factors in Advanced Diabetic Neuropathy Does Not Lead to Neural Regeneration despite Pancreas and Kidney Transplantation.
Saudek F; Cahová M; Havrdová T; Zacharovová K; Daňková H; Voska L; Lánská V; Üçeyler N; Sommer C
J Diabetes Res; 2018; 2018():2309108. PubMed ID: 30648113
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of disease: role of neurotrophins in diabetes and diabetic neuropathy.
Verge VM; Andreassen CS; Arnason TG; Andersen H
Handb Clin Neurol; 2014; 126():443-60. PubMed ID: 25410238
[TBL] [Abstract][Full Text] [Related]
33. The role of neurotrophic factors in disorders of peripheral nerves and motor neurons.
Yuen EC
Phys Med Rehabil Clin N Am; 2001 May; 12(2):293-306, viii. PubMed ID: 11345008
[TBL] [Abstract][Full Text] [Related]
34. Development of recombinant human nerve growth factor (rhNGF) as a treatment for peripheral neuropathic disease.
Rogers BC
Neurotoxicology; 1996; 17(3-4):865-70. PubMed ID: 9086510
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor.
Ohi T; Saita K; Furukawa S; Ohta M; Hayashi K; Matsukura S
Exp Neurol; 1998 Jun; 151(2):215-20. PubMed ID: 9628756
[TBL] [Abstract][Full Text] [Related]
36. Neurotrophins and other growth factors in diabetic neuropathy.
Zochodne DW
Semin Neurol; 1996 Jun; 16(2):153-61. PubMed ID: 8987129
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of peripheral neuropathies with neutrotrophic factors: animal models and clinical trials].
Pradat PF
Rev Neurol (Paris); 2003 Feb; 159(2):147-61. PubMed ID: 12660566
[TBL] [Abstract][Full Text] [Related]
38. Promoting neurotrophic effects by GPCR ligands.
Jeanneteau F; Chao MV
Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
[TBL] [Abstract][Full Text] [Related]
39. Emerging opportunities in peripheral neuropathy. Preface.
Said G; Bril V
Eur Neurol; 1999; 41 Suppl 1():1-2. PubMed ID: 10223842
[No Abstract] [Full Text] [Related]
40. Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons.
Koliatsos VE; Price DL; Gouras GK; Cayouette MH; Burton LE; Winslow JW
J Comp Neurol; 1994 May; 343(2):247-62. PubMed ID: 8027442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
